These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 7890907)

  • 1. Differential sensitivity of hepatitis C virus quasispecies to interferon-alpha therapy.
    Mizokami M; Lau JY; Suzuki K; Nakano T; Gojobori T
    J Hepatol; 1994 Nov; 21(5):884-6. PubMed ID: 7890907
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pretreatment virus load and multiple amino acid substitutions in the interferon sensitivity-determining region predict the outcome of interferon treatment in patients with chronic genotype 1b hepatitis C virus infection.
    Chayama K; Tsubota A; Kobayashi M; Okamoto K; Hashimoto M; Miyano Y; Koike H; Kobayashi M; Koida I; Arase Y; Saitoh S; Suzuki Y; Murashima N; Ikeda K; Kumada H
    Hepatology; 1997 Mar; 25(3):745-9. PubMed ID: 9049229
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Deep sequencing and phylogenetic analysis of variants resistant to interferon-based protease inhibitor therapy in chronic hepatitis induced by genotype 1b hepatitis C virus.
    Sato M; Maekawa S; Komatsu N; Tatsumi A; Miura M; Muraoka M; Suzuki Y; Amemiya F; Takano S; Fukasawa M; Nakayama Y; Yamaguchi T; Uetake T; Inoue T; Sato T; Sakamoto M; Yamashita A; Moriishi K; Enomoto N
    J Virol; 2015 Jun; 89(11):6105-16. PubMed ID: 25810555
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selection of hepatitis C virus quasispecies during interferon treatment.
    Sakuma I; Enomoto N; Kurosaki M; Marumo F; Sato C
    Arch Virol; 1996; 141(10):1921-32. PubMed ID: 8920825
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of viral quasispecies on effectiveness of interferon therapy in chronic hepatitis C patients.
    Kanazawa Y; Hayashi N; Mita E; Li T; Hagiwara H; Kasahara A; Fusamoto H; Kamada T
    Hepatology; 1994 Nov; 20(5):1121-30. PubMed ID: 7523271
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quasispecies nature of hepatitis C virus and response to alpha interferon: significance as a predictor of direct response to interferon.
    Toyoda H; Kumada T; Nakano S; Takeda I; Sugiyama K; Osada T; Kiriyama S; Sone Y; Kinoshita M; Hadama T
    J Hepatol; 1997 Jan; 26(1):6-13. PubMed ID: 9148023
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quasispecies heterogeneity and constraints on the evolution of the 5' noncoding region of hepatitis C virus (HCV): relationship with HCV resistance to interferon-alpha therapy.
    Soler M; Pellerin M; Malnou CE; Dhumeaux D; Kean KM; Pawlotsky JM
    Virology; 2002 Jun; 298(1):160-73. PubMed ID: 12093183
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Relationship between diversity of hepatitis C virus quasispecies and viremia, activity of liver disease and response to interferon therapy].
    Tang X; Qian K; Yuan X; Johnson YN
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2002 Jun; 16(2):128-31. PubMed ID: 12196822
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of hepatitis C virus quasispecies heterogeneity by gel shift analysis: correlation with response to interferon therapy.
    Polyak SJ; Faulkner G; Carithers RL; Corey L; Gretch DR
    J Infect Dis; 1997 May; 175(5):1101-7. PubMed ID: 9129072
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fluctuation of hepatitis C virus quasispecies in persistent infection and interferon treatment revealed by single-strand conformation polymorphism analysis.
    Enomoto N; Kurosaki M; Tanaka Y; Marumo F; Sato C
    J Gen Virol; 1994 Jun; 75 ( Pt 6)():1361-9. PubMed ID: 8207402
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic heterogeneity of hypervariable region 1 of the hepatitis C virus (HCV) genome and sensitivity of HCV to alpha interferon therapy.
    Sandres K; Dubois M; Pasquier C; Payen JL; Alric L; Duffaut M; Vinel JP; Pascal JP; Puel J; Izopet J
    J Virol; 2000 Jan; 74(2):661-8. PubMed ID: 10623727
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutations within the hepatitis C virus genotype 1b E2-PePHD domain do not correlate with treatment outcome.
    Gaudy C; Lambelé M; Moreau A; Veillon P; Lunel F; Goudeau A
    J Clin Microbiol; 2005 Feb; 43(2):750-4. PubMed ID: 15695675
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatitis C Virus: Viral Quasispecies and Genotypes.
    Tsukiyama-Kohara K; Kohara M
    Int J Mol Sci; 2017 Dec; 19(1):. PubMed ID: 29271914
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The degree of variability in the amino terminal region of the E2/NS1 protein of hepatitis C virus correlates with responsiveness to interferon therapy in viremic patients.
    Okada S; Akahane Y; Suzuki H; Okamoto H; Mishiro S
    Hepatology; 1992 Sep; 16(3):619-24. PubMed ID: 1380477
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutations in NS5A region of hepatitis C virus genome correlate with presence of NS5A antibodies and response to interferon therapy for most common European hepatitis C virus genotypes.
    Frangeul L; Cresta P; Perrin M; Lunel F; Opolon P; Agut H; Huraux JM
    Hepatology; 1998 Dec; 28(6):1674-9. PubMed ID: 9828234
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mutations in the nonstructural 5A gene of European hepatitis C virus isolates and response to interferon alfa.
    Zeuzem S; Lee JH; Roth WK
    Hepatology; 1997 Mar; 25(3):740-4. PubMed ID: 9049228
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatitis C virus quasispecies populations during chronic hepatitis C infection.
    Enomoto N; Sato C
    Trends Microbiol; 1995 Nov; 3(11):445-7. PubMed ID: 8574520
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evolutionary study of HVR1 of E2 in chronic hepatitis C virus infection.
    Alfonso V; Flichman DM; Sookoian S; Mbayed VA; Campos RH
    J Gen Virol; 2004 Jan; 85(Pt 1):39-46. PubMed ID: 14718618
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mutations in the nonstructural protein 5A gene and response to interferon in patients with chronic hepatitis C virus 1b infection.
    Enomoto N; Sakuma I; Asahina Y; Kurosaki M; Murakami T; Yamamoto C; Ogura Y; Izumi N; Marumo F; Sato C
    N Engl J Med; 1996 Jan; 334(2):77-81. PubMed ID: 8531962
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heterogeneity in E2 region of GBV-C/hepatitis G virus and hepatitis C virus.
    Kato T; Mizokami M; Nakano T; Orito E; Ohba K; Kondo Y; Tanaka Y; Ueda R; Mukaide M; Fujita K; Yasuda K; Iino S
    J Med Virol; 1998 Jun; 55(2):109-17. PubMed ID: 9598930
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.